Skip to content 
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper platform for bacterial and fungal identification and establish, DNA test strips, and; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was founded in 1960 and is headquartered in Billerica, Massachusetts. more
| Time Frame | BRKR | Sector | S&P500 |
|---|---|---|---|
| 1-Week Return | -12.93% | -0.03% | -1.38% |
| 1-Month Return | -28.24% | 0.59% | -1.81% |
| 3-Month Return | -12.63% | 3.23% | 1.38% |
| 6-Month Return | 5.7% | 18.29% | 5.68% |
| 1-Year Return | -28.62% | 7.71% | 11.74% |
| 3-Year Return | -51.82% | 18.03% | 65.15% |
| 5-Year Return | -42.49% | 35.78% | 73.68% |
| 10-Year Return | 47.87% | 140.42% | 260.03% |
| Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | 5YR TREND | |
|---|---|---|---|---|---|---|
| Total Revenue | 2.42B | 2.53B | 2.96B | 3.37B | 3.44B | [{"date":"2021-12-31","value":70.36,"profit":true},{"date":"2022-12-31","value":73.64,"profit":true},{"date":"2023-12-31","value":86.27,"profit":true},{"date":"2024-12-31","value":97.96,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Cost of Revenue | 1.21B | 1.23B | 1.45B | 1.72B | 1.86B | [{"date":"2021-12-31","value":65,"profit":true},{"date":"2022-12-31","value":65.9,"profit":true},{"date":"2023-12-31","value":78.07,"profit":true},{"date":"2024-12-31","value":92.37,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Gross Profit | 1.21B | 1.31B | 1.51B | 1.65B | 1.58B | [{"date":"2021-12-31","value":73.33,"profit":true},{"date":"2022-12-31","value":79.16,"profit":true},{"date":"2023-12-31","value":91.74,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":95.65,"profit":true}] |
| Gross Margin | 50.03% | 51.59% | 51.05% | 49.00% | 45.91% | [{"date":"2021-12-31","value":96.96,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":98.94,"profit":true},{"date":"2024-12-31","value":94.97,"profit":true},{"date":"2025-12-31","value":88.98,"profit":true}] |
| Operating Expenses | 796.30M | 873.00M | 1.08B | 1.40B | 1.51B | [{"date":"2021-12-31","value":52.75,"profit":true},{"date":"2022-12-31","value":57.83,"profit":true},{"date":"2023-12-31","value":71.31,"profit":true},{"date":"2024-12-31","value":92.51,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Operating Income | 413.30M | 432.70M | 436.90M | 253.10M | 68.20M | [{"date":"2021-12-31","value":94.6,"profit":true},{"date":"2022-12-31","value":99.04,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":57.93,"profit":true},{"date":"2025-12-31","value":15.61,"profit":true}] |
| Total Non-Operating Income/Expense | (39.40M) | (36.60M) | 102.90M | (86.50M) | - | [{"date":"2021-12-31","value":-38.29,"profit":false},{"date":"2022-12-31","value":-35.57,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-84.06,"profit":false},{"date":"2025-12-31","value":"-","profit":true}] |
| Pre-Tax Income | 393.60M | 414.90M | 546.20M | 205.20M | 29.30M | [{"date":"2021-12-31","value":72.06,"profit":true},{"date":"2022-12-31","value":75.96,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":37.57,"profit":true},{"date":"2025-12-31","value":5.36,"profit":true}] |
| Income Taxes | 113.00M | 116.40M | 117.70M | 91.40M | 29.30M | [{"date":"2021-12-31","value":96.01,"profit":true},{"date":"2022-12-31","value":98.9,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":77.66,"profit":true},{"date":"2025-12-31","value":24.89,"profit":true}] |
| Income After Taxes | 280.60M | 298.50M | 428.50M | 113.80M | - | [{"date":"2021-12-31","value":65.48,"profit":true},{"date":"2022-12-31","value":69.66,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":26.56,"profit":true},{"date":"2025-12-31","value":"-","profit":true}] |
| Income From Continuous Operations | 280.60M | 298.50M | 322.20M | 113.80M | - | [{"date":"2021-12-31","value":87.09,"profit":true},{"date":"2022-12-31","value":92.64,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":35.32,"profit":true},{"date":"2025-12-31","value":"-","profit":true}] |
| Income From Discontinued Operations | - | - | - | - | - | [{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}] |
| Net Income | 277.10M | 296.60M | 427.20M | 113.10M | - | [{"date":"2021-12-31","value":64.86,"profit":true},{"date":"2022-12-31","value":69.43,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":26.47,"profit":true},{"date":"2025-12-31","value":"-","profit":true}] |
| EPS (Diluted) | 2.10 | 2.34 | 2.68 | 2.41 | 1.56 | [{"date":"2021-12-31","value":78.36,"profit":true},{"date":"2022-12-31","value":87.31,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":89.93,"profit":true},{"date":"2025-12-31","value":58.21,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
| BRKR | |
|---|---|
| Cash Ratio | 0.23 |
| Current Ratio | 1.73 |
| Quick Ratio | 0.87 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
| BRKR | |
|---|---|
| ROA (LTM) | 2.44% |
| ROE (LTM) | -0.38% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
| BRKR | |
|---|---|
| Debt Ratio Lower is generally better. Negative is bad. | 0.60 |
| Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.40 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
| BRKR | |
|---|---|
| Trailing PE | NM |
| Forward PE | 16.45 |
| P/S (TTM) | 1.61 |
| P/B | 2.24 |
| Price/FCF | 27 |
| EV/R | 2.07 |
| EV/Ebitda | 15.60 |
| PEG | 3.64 |
Bruker Corporation (BRKR) share price today is $36.51
Yes, Indians can buy shares of Bruker Corporation (BRKR) on Vested. To buy
Yes, you can purchase fractional shares of Bruker Corporation (BRKR) via the Vested app. You can start investing in Bruker Corporation (BRKR) with a minimum investment of $1.
You can invest in shares of Bruker Corporation (BRKR) via Vested in three simple steps:
The 52-week high price of Bruker Corporation (BRKR) is $56.22. The 52-week low price of Bruker Corporation (BRKR) is $28.46.
The price-to-earnings (P/E) ratio of Bruker Corporation (BRKR) is
The price-to-book (P/B) ratio of Bruker Corporation (BRKR) is 2.24
The dividend yield of Bruker Corporation (BRKR) is 0.48%
The market capitalization of Bruker Corporation (BRKR) is $5.55B
The stock symbol (or ticker) of Bruker Corporation is BRKR
Consider the share price of Bruker Corporation as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Bruker Corporation has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.
When investing in Bruker Corporation shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Bruker Corporation stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.
Rather than merely checking the share price of Bruker Corporation and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Bruker Corporation stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.
Link copied 
